Skip to main content
OpenTrials

Clinical trial condition

Relapsing Multiple Sclerosis

Explore clinical trials studying Relapsing Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

68 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Relapsing Multiple Sclerosis trial results

Completed

An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumab

NCT04353492

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Fullerton Neuro and Headache Ctr Fullerton, California, United States
  • CU Anschutz Med Campus Aurora, Colorado, United States
  • Christiana Care Health Services Newark, Delaware, United States
  • Memorial Healthcare System Hollywood, Florida, United States
View all 123 locations
View Trial Details
Completed

Characterizing the Use of Ofatumumab in a Real World Setting

NCT05090033

Conditions
Relapsing Multiple Sclerosis
Locations
  • Novartis Investigative Site Concord, New South Wales, Australia
  • Novartis Investigative Site Southport, Queensland, Australia
  • Novartis Investigative Site Clayton, Victoria, Australia
  • Novartis Investigative Site Melbourne, Victoria, Australia
View Trial Details
Completed

A Single Arm Study Evaluating the Efficacy, Safety and Tolerability of Ofatumumab in Patients With Relapsing Multiple Sclerosis

NCT04486716

Conditions
Relapsing Multiple Sclerosis
Locations
  • Alabama Neurology Associates PC Birmingham, Alabama, United States
  • Ctr for Neurology and Spine Phoenix, Arizona, United States
  • Neuro Center Pomona, California, United States
  • UC Health Neuroscience Ctr Aurora, Colorado, United States
View all 20 locations
View Trial Details
Completed

Study of Efficacy and Safety of Ofatumumab in Relapsing Multiple Sclerosis (RMS) Patients in China

NCT05199571

Conditions
Relapsing Multiple Sclerosis
Locations
  • Novartis Investigative Site Lanzhou, Gansu, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
View all 18 locations
View Trial Details
Completed

Long Term Safety and Efficacy Study of Tolebrutinib (SAR442168) in Participants With Relapsing Multiple Sclerosis

NCT03996291

Conditions
Relapsing Multiple Sclerosis
Locations
  • North Central Neurology Associates, PC Site Number : 8400005 Cullman, Alabama, United States
  • Neurology Associates, PA Site Number : 8400002 Maitland, Florida, United States
  • University of South Florida Site Number : 8400009 Tampa, Florida, United States
  • Velocity Clinical Research Site Number : 8400007 Savannah, Georgia, United States
View all 37 locations
View Trial Details
Completed

Dose-finding Study for SAR442168 in Relapsing Multiple Sclerosis

NCT03889639

Conditions
Relapsing Multiple Sclerosis
Locations
  • Investigational Site Number 8400005 Cullman, Alabama, United States
  • Investigational Site Number 8400002 Maitland, Florida, United States
  • Investigational Site Number 8400004 Sunrise, Florida, United States
  • Investigational Site Number 8400009 Tampa, Florida, United States
View all 48 locations
View Trial Details
Completed

A Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Radiological And Clinical Effects Of Subcutaneous Ocrelizumab Versus Intravenous Ocrelizumab In Patients With Multiple Sclerosis

NCT05232825

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +11 more
Locations
  • Neurology Associates PA Maitland, Florida, United States
  • University of South Florida Tampa, Florida, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • Memorial Healthcare Institute for Neurosciences and Multiple Sclerosis Owosso, Michigan, United States
View all 37 locations
View Trial Details
Completed

Exploring the Profiles of RMS Patients on Ofatumumab or Ocrelizumab in a Real-World Setting in the Gulf

NCT05266469

Conditions
Relapsing Multiple Sclerosis
Locations
  • Novartis Investigative Site Al Ain Abu Dhabi, United Arab Emirates
  • Novartis Investigative Site Sharjah city, United Arab Emirates
  • Novartis Investigative Site Abu Dhabi, United Arab Emirates
  • Novartis Investigative Site Abu Dhabi, United Arab Emirates
View Trial Details

Related conditions